|
| Home | Articles | Resources | About us | Quick Tips | Educational materials |
Find us again! Moodletter provides information, hope and help to people living with depression, anxiety or bipolar disorder and those who care for them. ©2006-2011 Deborah Wiig
|
|
Have
you read these?
|
|||||||||
|
The U.S. Food and Drug Administration (FDA) has approved once-daily Seroquel XR(R) (quetiapine fumarate) Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar disorder, the manic and mixed episodes associated with bipolar I disorder, and the maintenance treatment of bipolar I disorder as add-on therapy to lithium or divalproex. Seroquel XR is the first medication approved by the FDA for the once-daily acute treatment of both depressive and manic episodes associated with bipolar disorder. Seroquel XR(R) is made by AstraZeneca. "When people think about bipolar disorder it is important to remember how debilitating the depressive episodes of the disease can be. In fact, in the long term, patients with bipolar disorder experience depressive symptoms three times longer than manic symptoms," said Dr. Trisha Suppes, Professor of Psychiatry and Behavioral Sciences, Stanford University Medical Center and VA Palo Alto Health Care System.
|
Seroquel XR can now be used to treat both kinds of symptoms. Side effects of Seroquel XR may include sleepiness, dry mouth, increased appetite, weight gain, indigestion and fatigue. Visit AstraZeneca for important safety information about Seroquel. Find out more about the symptoms of bipolar disorder. Related articlesCoping with medication side effects Tips for managing your medications Understanding bipolar disorder More articles
Page updated December 1, 2008
|
||||||||||
